文献速递癫痫认知障碍与痴呆

阿尔茨海默病伴癫痫患者的癫痫灶与tau蛋白及淀粉样蛋白沉积和脑萎缩位置的关联

Association of Seizure Foci and Location of Tau and Amyloid Deposition and Brain Atrophy in Patients With Alzheimer Disease and Seizures.
PubMed 文献 · Neurology · 2024-09-27

本横断面研究对8例早期临床阶段阿尔茨海默病(AD)合并晚发性局灶性癫痫(AD-Ep)患者和14例无癫痫AD患者(AD-NoEp)进行tau和淀粉样蛋白PET、脑MRI及夜间头皮EEG。AD-Ep组癫痫半球tau沉积显著更高且不对称,淀粉样蛋白和萎缩亦较高但不对称程度较小;与AD-NoEp组相比,AD-Ep组tau不对称性显著更大,淀粉样蛋白和萎缩不对称性有趋势。

要点

  • AD-Ep组癫痫半球tau沉积显著高于对侧半球,呈高度不对称模式。
  • AD-Ep组癫痫半球淀粉样蛋白沉积和皮层萎缩也较高,但不对称程度小于tau。
  • 与AD-NoEp组相比,AD-Ep组tau不对称性显著更大,双侧淀粉样蛋白负荷显著更高。

核心结论

  • 在早期临床阶段AD中,癫痫灶与tau沉积、淀粉样蛋白沉积和神经变性存在空间关联。
  • 在横断面研究和小样本量的局限性内,这些发现有助于理解AD的临床病理异质性,表明局灶性癫痫与AD的偏侧化病理相关。

研究设计与样本

  • 横断面研究,纳入8例早期临床阶段AD合并晚发性、其他原因无法解释的局灶性癫痫患者(AD-Ep)和14例无癫痫AD患者(AD-NoEp)。
  • 进行tau和淀粉样蛋白PET成像、脑MRI和夜间头皮EEG;根据EEG和癫痫发作症状学确定癫痫定位。
  • 量化脑区tau沉积、淀粉样蛋白沉积和萎缩,计算不对称指数。

主要发现

  • AD-Ep组PET成像时平均年龄69.5±4.2岁,AD-NoEp组平均年龄71.7±9.8岁。
  • AD-Ep组癫痫半球tau沉积显著高于对侧半球,呈高度不对称模式。
  • AD-Ep组癫痫半球淀粉样蛋白沉积和皮层萎缩也较高,但不对称程度小于tau。
  • 与AD-NoEp组相比,AD-Ep组tau不对称性显著更大,淀粉样蛋白和萎缩不对称性有趋势。
  • 与AD-NoEp组相比,AD-Ep组双侧淀粉样蛋白负荷显著更高,癫痫半球tau负荷有趋势。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 横断面研究。
  • 样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Alzheimer disease (AD) is associated with a 2 to 3-fold increased risk of developing late-onset focal epilepsy, yet it remains unclear how development of focal epilepsy in AD is related to AD pathology. The objective of this study was to examine spatial relationships between the epileptogenic zone and tau deposition, amyloid deposition, and brain atrophy in individuals with AD who developed late-onset, otherwise unexplained focal epilepsy. We hypothesized that if network hyperexcitability is mechanistically linked to AD pathology, then there would be increased tau and amyloid deposition within the epileptogenic hemisphere. METHODS: In this cross-sectional study, we performed tau and amyloid PET imaging, brain MRI, and overnight scalp EEG in individuals with early clinical stages of AD who developed late-onset, otherwise unexplained focal epilepsy (AD-Ep). Participants were referred from epilepsy and memory disorders clinics at our institutions. We determined epilepsy localization based on EEG findings and seizure semiology. We quantified tau deposition, amyloid deposition, and atrophy across brain regions and calculated asymmetry indices for these measures. We compared findings in AD-Ep with those in a control AD group without epilepsy (AD-NoEp). RESULTS: The AD-Ep group included 8 individuals with a mean age of 69.5 ± 4.2 years at PET imaging. The AD-NoEp group included 14 individuals with a mean age of 71.7 ± 9.8 years at PET imaging. In AD-Ep, we found a highly asymmetric pattern of tau deposition, with significantly greater tau in the epileptogenic hemisphere. Amyloid deposition and cortical atrophy were also greater in the epileptogenic hemisphere, although the magnitudes of asymmetry were reduced compared with tau. Compared with AD-NoEp, the AD-Ep group had significantly greater tau asymmetry and trends toward greater asymmetry of amyloid and atrophy. AD-Ep also had significantly greater amyloid burden bilaterally and trends toward greater tau burden within the epileptogenic hemisphere, compared with AD-NoEp. DISCUSSION: Our results reveal a spatial association between the epileptogenic focus and tau deposition, amyloid deposition, and neurodegeneration in early clinical stages of AD. Within the limitations of a cross-sectional study with small sample sizes, these findings contribute to our understanding of the clinicopathologic heterogeneity of AD, demonstrating an association between focal epilepsy and lateralized pathology in AD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Lam AD, Thibault EG, Mayblyum DV, et al. Association of Seizure Foci and Location of Tau and Amyloid Deposition and Brain Atrophy in Patients With Alzheimer Disease and Seizures. Neurology. 2024. PMID: 39331846. doi:10.1212/WNL.0000000000209920

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。